Revenue from Contracts with Customers (Tables)

6 Months Ended

Mar. 31, 2023

Revenue from Contract with Customer [Abstract]

Revenue by Reporting Unit

	Three months ended March 31,				Six months ended March 31,
	2023		2022			2023	2022
Significant Business Line
Life Sciences Products, excluding B Medical	$	43,738	$	53,615	$	91,576	$	103,493
B Medical		15,122		-		56,944		-
Sample Repository Solutions		27,305		26,929		54,921		52,805
Genomic Services		62,236		65,000		123,326		128,898
Total	$	148,401	$	145,544	$	326,767	$	285,196

Remaining Performance Obligations

	As of March 31, 2023
	Less than 1 Year		Greater than 1 Year		Total
Remaining Performance Obligations	$	58,944	$	32,516	$	91,460